Rates of newly diagnosed breast cancer at commission on cancer facilities during the early phase of the COVID‐19 pandemic
Abstract Introduction The objective of this study was to examine the impact of the early part of the COVID‐19 pandemic on the number of newly diagnosed breast cancer cases at Commission on Cancer (CoC)‐accredited facilities relative to the United States (U.S.) population. Methods We examined the inc...
Main Authors: | Marie Fefferman, Kristine Kuchta, Chi‐Hsiung Wang, Kyra Nicholson, Katherine Kopkash, Catherine Pesce, Elizabeth Poli, Thomas W. Smith, Katharine Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6874 |
Similar Items
-
Changes in the treatment rate of patients newly diagnosed with stage IV cancer near the end of life from 2012 to 2017 in Korea
by: Kyuwoong Kim, et al.
Published: (2023-02-01) -
Individualized assessment of risk and overall survival in patients newly diagnosed with primary osseous spinal neoplasms with synchronous distant metastasis
by: Yuexin Tong, et al.
Published: (2022-08-01) -
Establishment of Korean prostate cancer database by the Korean Urological Oncology Society
by: Hanjong Ahn, et al.
Published: (2017-11-01) -
The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer
by: Daniel C. Parker, et al.
Published: (2020-02-01) -
O câncer de cabeça e pescoço no Brasil
by: Laís Guedes Alcoforado de Carvalho, et al.